FDA Expands New Treatment for Metastatic Prostate Cancer: Targets a Protein Called PSMA

FDA Expands New Treatment for Metastatic Prostate Cancer: Targets a Protein...

0
President Joseph Biden is one of an estimated 120,000 men living with stage 4 prostate cancer.  Fortunately, there are effective treatments that can slow or...
Merus (MRUS) Stock: Analysts Rally Behind Biotech After Cancer Treatment Breakthrough

Merus (MRUS) Stock: Analysts Rally Behind Biotech After Cancer Treatment Breakthrough

0
TLDR Merus (MRUS) receives consensus “Buy” rating from 16 analysts with average price target of $86 BofA raises price target to $92 from $70 following strong...
AdvanCell

Australian radiopharma players take on big pharma

0
Published on May 26, 2025 Radiopharma therapies targeting prostate cancer are driving a new gold rush in biotech—and Australia is leading the charge with technology so...
Pioneering science to deliver the oncology breakthroughs of tomorrow

Pioneering science to deliver the oncology breakthroughs of tomorrow

0
Tadaaki Taniguchi, M.D., Ph.D., Chief Research & Development Officer, Astellas | Astellas’ Chief R&D Officer, Tadaaki Taniguchi, shares how Astellas is advancing next-generation modalities...
Professor Go Young-il leads breakthroughs in treating acute leukemia at Seoul National University

Professor Go Young-il leads breakthroughs in treating acute leukemia at Seoul...

0
Professor Go Young-il leads breakthroughs in treating acute leukemia at Seoul National University Professor Ko Young-il advances innovative strategies for blood cancer therapy at...

Recent Posts